Antitumor compound and therapeutic uses thereof

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/403 (2006.01) A61P 9/00 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2493202

The use of an arylidene 2-indolinone derivative for treating tumors involving Met, PDGF-R, FGF-RI, FGF-R3 and Kit tyrosine kinases, or the oncoproteins of Ret family is disclosed. The invention also provides pharmaceutical compositions comprising laid arylidene 2-indolinone derivative as well as a kit comprising, in separate containers, said derivative and an anti-cancer or anti-tumor agent.

L'invention concerne l'utilisation d'un dérivé arylidène 2-indolinone pour le traitement de tumeurs impliquant des Met, des PDGF-R, des FGF-RI, des FGF-R3 et des Kit tyrosine kinases, ou les oncoprotéines de la famille Ret. L'invention concerne également des compositions pharmaceutiques comprenant ledit dérivé arylidène 2-indolinone, ainsi qu'une trousse comprenant, dans des contenants séparés, ledit dérivé et un agent anticancéreux ou antitumoral.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antitumor compound and therapeutic uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antitumor compound and therapeutic uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor compound and therapeutic uses thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2013342

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.